By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Zalicus Pharmaceuticals Ltd. 

301 – 2389 Health Sciences Mall

Vancouver  British Columbia  V6T 1Z3  Canada
Phone: 604-909-2530 Fax: 604-909-2538


Company News
CombinatoRx, Incorporated (CRXX) and Neuromed Pharmaceuticals Close Merger 12/22/2009 8:54:58 AM
Stockholders of CombinatoRx, Incorporated (CRXX) and Neuromed Pharmaceuticals Vote for Merger 12/18/2009 11:56:01 AM
FDA Extends NDA Review for Neuromed Pharmaceuticals's Exalgo(TM) Extended-Release Tablets 11/20/2009 8:31:56 AM
CombinatoRx, Incorporated (CRXX) And Neuromed Pharmaceuticals Receive FDA Feedback on New Drug Application for Exalgo Extended-Release Tablets 11/16/2009 9:40:13 AM
CombinatoRx, Incorporated (CRXX) and Neuromed Pharmaceuticals Announce Posting of Briefing Documents for FDA Advisory Committee 9/22/2009 9:11:03 AM
Neuromed Pharmaceuticals Announces Sale of U.S. Rights to Drug Candidate Exalgo(TM) (hydromorphone HCl) Extended-Release Tablets (CII) to Mallinckrodt Inc. 6/17/2009 7:26:33 AM
Neuromed Pharmaceuticals Announces that Merck & Co., Inc. (MRK) (JOBS) Terminates Research Collaboration and License Agreement for Compounds Targeting N-Type Calcium Channels 6/11/2009 8:31:08 AM
Neuromed Pharmaceuticals Announces Exalgo(TM) Meets Primary Efficacy Endpoint in Pivotal Phase 3 Trial 3/23/2009 7:24:34 AM
Neuromed Pharmaceuticals Completes Enrollment for Phase 3 Chronic Low Back Pain Clinical Trial of NMED-1077 11/20/2008 8:05:02 AM
Neuromed Pharmaceuticals's Sean Cunliffe Named to PharmaVOICE's 2008 Top "100 Most Inspiring People in the Life Sciences Industry" 7/23/2008 4:29:26 PM